Evidence map›Paper›PMID 24616734›Full record

ArticleFrontiers in genetics2014

Modular network construction using eQTL data: an analysis of computational costs and benefits.

Yen-Yi Ho, Leslie M Cope, Giovanni Parmigiani

Abstract read
In one paragraph

Article in Frontiers in genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yen-Yi HoDivision of Biostatistics, School of Public Health, University of Minnesota Minneapolis, MN, USA.
Leslie M CopeThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, MD, USA.
Giovanni ParmigianiDana-Farber Cancer Institute and Harvard School of Public Health Boston, MA, USA.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Research CoreU54MD008620 · NIMHD · UNIVERSITY OF MINNESOTA · PI FOUAD, MONA N., SHIKANY, JAMES M · 2013 to 2017
$13.5M
UAB / UMN SPORE in Pancreatic CancerP50CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J · 2010 to 2014
$11.1M
GENETIC ANALYSIS OF COMMON DISEASES: AN EVALUATIONR01GM031575 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI ALMASY, LAURA A. · 1985 to 2016
$7.8M
Genome-wide analysis of genetic variation expressionR01HG002386 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI SPIELMAN, RICHARD S · 2001 to 2006
$4.7M
NCATS NIH HHS UL1 TR000114NCI NIH HHS P30 CA077598NCI NIH HHS P50 CA101955NHGRI NIH HHS R01 HG002386NIGMS NIH HHS R01 GM031575NIMHD NIH HHS U54 MD008620
6 · The paper itself

Abstract

backgroundIn this paper, we consider analytic methods for the integrated analysis of genomic DNA variation and mRNA expression (also named as eQTL data), to discover genetic networks that are associated with a complex trait of interest. Our focus is the systematic evaluation of the trade-off between network size and network search efficiency in the construction of these networks.

resultsWe developed a modular approach to network construction, building from smaller networks to larger ones, thereby reducing the search space while including more variables in the analysis. The goal is achieving a lower computational cost while maintaining high confidence in the resulting networks. As demonstrated in our simulation results, networks built in this way have low node/edge false discovery rate (FDR) and high edge sensitivity comparing to greedy search. We further demonstrate our method in a data set of cellular responses to two chemotherapeutic agents: docetaxel and 5-fluorouracil (5-FU), and identify biologically plausible networks that might describe resistances to these drugs.

conclusionIn this study, we suggest that guided comprehensive searches for parsimonious networks should be considered as an alternative to greedy network searches.

Indexed as

Bayesian networkschemotherapy resistanceeQTLnetwork variable selectionsearch algorithm

Identifiers

PMID24616734
PMCPMC3935177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.